Literature DB >> 25519191

Pulmonary vascular remodeling before and after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a cardiac magnetic resonance study.

Andreas Rolf1, Johannes Rixe, Won K Kim, Stefan Guth, Nils Körlings, Helge Möllmann, Holger M Nef, Christoph Liebetrau, Gabriele Krombach, Thorsten Kramm, Eckhard Mayer, Christian W Hamm.   

Abstract

Phase-contrast magnetic resonance imaging (PC-MRI) offers a range of surrogate markers to quantify the hemodynamic changes associated with chronic thromboembolic pulmonary hypertension (CTEPH). Our aim was to noninvasively monitor effects of pulmonary vascular remodeling before and after endarterectomy (PEA) in patients with CTEPH by using PC-MRI. Fifty-seven consecutive patients (mean age 56.7 ± 16, 28 female) underwent PC-MRI before and after PEA as part of their peri-operative routine workup. Pulmonary artery (PA) maximum flow velocity (maxV), acceleration time/ejection time (AT/ET), distensibility [(PA maximum area - PA minimum area)/PA minimum area], mid-systolic flow deceleration (notch), and the timing of deceleration (notch ratio) were recorded. Mean PA pressure was obtained from standard right heart catheter procedures. maxV and AT/ET were decreased before PEA and significantly improved afterwards (60.8 ± 16 vs. 73.8 ± 19 cm/s, p = 0.007; 0.32 ± 0.06 vs. 0.36 ± 0.09, p = 0.0015). Surprisingly, distensibility did not change significantly (30 ± 19 vs. 26 ± 12%, p = 0.11). Forty-five patients (78%) had a systolic notch before PEA that persisted in only 10 (18%; p = 0.00001). Among patients with a persisting notch, the notch ratio did not significantly increase (1.3 ± 0.2 vs. 1.6 ± 1.5, p = 0.32). Our data show early PA reverse remodeling after PEA. Flow velocities increase while PA flow wave reflections represented by mid-systolic flow deceleration are abolished. In some patients a mid-systolic notch persists, suggesting increased downstream resistance as a consequence of small vessel arteriopathy.

Entities:  

Mesh:

Year:  2014        PMID: 25519191     DOI: 10.1007/s10554-014-0580-z

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  30 in total

Review 1.  Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension.

Authors:  Irene Lang
Journal:  Br J Haematol       Date:  2010-03-16       Impact factor: 6.998

2.  Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension.

Authors:  Sebastian Ley; Derliz Mereles; Michael Puderbach; Ekkehard Gruenig; Helena Schöck; Monika Eichinger; Julia Ley-Zaporozhan; Christian Fink; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2007-01-16       Impact factor: 5.315

3.  Cardiac magnetic resonance imaging-derived pulmonary artery distensibility index correlates with pulmonary artery stiffness and predicts functional capacity in patients with pulmonary arterial hypertension.

Authors:  Ki-Woon Kang; Hyuk-Jae Chang; Young-Jin Kim; Byoung-Wook Choi; Hye Sun Lee; Woo-In Yang; Chi-Young Shim; Jongwon Ha; Namsik Chung
Journal:  Circ J       Date:  2011-07-15       Impact factor: 2.993

4.  Noninvasive assessment of pulmonary hemodynamics in patients with chronic thromboembolic pulmonary hypertension by high temporal resolution phase-contrast MRI: correlation with simultaneous invasive pressure recordings.

Authors:  Karl-Friedrich Kreitner; Gesine Maria Wirth; Frank Krummenauer; Stefan Weber; Michael Bernhard Pitton; Jens Schneider; Eckhard Mayer; Christoph Dueber
Journal:  Circ Cardiovasc Imaging       Date:  2013-07-17       Impact factor: 7.792

Review 5.  Chronic major-vessel thromboembolic pulmonary hypertension.

Authors:  K M Moser; W R Auger; P F Fedullo
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

6.  Quantification of right ventricular afterload in patients with and without pulmonary hypertension.

Authors:  Jan-Willem Lankhaar; Nico Westerhof; Theo J C Faes; Koen M J Marques; J Tim Marcus; Piet E Postmus; Anton Vonk-Noordegraaf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-12       Impact factor: 4.733

7.  Predictors of outcome in chronic thromboembolic pulmonary hypertension.

Authors:  Diana Bonderman; Nika Skoro-Sajer; Johannes Jakowitsch; Christopher Adlbrecht; Daniela Dunkler; Sharokh Taghavi; Walter Klepetko; Meinhard Kneussl; Irene M Lang
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

8.  Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques.

Authors:  Karl-Friedrich Jakob Kreitner; Sebastian Ley; Hans-Ulrich Kauczor; Eckhard Mayer; Thorsten Kramm; Michael Bernhard Pitton; Frank Krummenauer; Manfred Thelen
Journal:  Radiology       Date:  2004-06-23       Impact factor: 11.105

9.  Pulmonary flow profile and distensibility following acute pulmonary embolism.

Authors:  Frederikus A Klok; Soha Romeih; Jos J M Westenberg; Lucia J M Kroft; Menno V Huisman; Albert de Roos
Journal:  J Cardiovasc Magn Reson       Date:  2011-02-18       Impact factor: 5.364

10.  Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.

Authors:  Andrew J Swift; Smitha Rajaram; Judith Hurdman; Catherine Hill; Christine Davies; Tom W Sproson; Allison C Morton; Dave Capener; Charlie Elliot; Robin Condliffe; Jim M Wild; David G Kiely
Journal:  JACC Cardiovasc Imaging       Date:  2013-06-13
View more
  2 in total

Review 1.  MR phase-contrast imaging in pulmonary hypertension.

Authors:  Ursula Reiter; Gert Reiter; Michael Fuchsjäger
Journal:  Br J Radiol       Date:  2016-04-06       Impact factor: 3.039

2.  Perioperative CTEPH patient monitoring with 2D phase-contrast MRI reflects clinical, cardiac and pulmonary perfusion changes after pulmonary endarterectomy.

Authors:  Christoph P Czerner; Christian Schoenfeld; Serghei Cebotari; Julius Renne; Till F Kaireit; Hinrich B Winther; Gesa H Pöhler; Karen M Olsson; Marius M Hoeper; Frank Wacker; Jens Vogel-Claussen
Journal:  PLoS One       Date:  2020-09-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.